Jane Street’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.6M | Buy |
212,200
+116,800
| +122% | +$16.4M | ﹤0.01% | 1462 |
|
|
2025
Q4 | $11.7M | Sell |
95,400
-18,000
| -16% | -$2.19M | ﹤0.01% | 2136 |
|
|
2025
Q3 | $12.6M | Sell |
113,400
-31,300
| -22% | -$3.56M | ﹤0.01% | 2131 |
|
|
2025
Q2 | $16M | Buy |
144,700
+19,400
| +15% | +$2.06M | ﹤0.01% | 1654 |
|
|
2025
Q1 | $14M | Buy |
125,300
+29,100
| +30% | +$3M | ﹤0.01% | 1607 |
|
|
2024
Q4 | $8.89M | Sell |
96,200
-60,100
| -38% | -$5.41M | ﹤0.01% | 1996 |
|
|
2024
Q3 | $13.1M | Sell |
156,300
-248,900
| -61% | -$19M | ﹤0.01% | 1645 |
|
|
2024
Q2 | $27.8M | Buy |
405,200
+117,500
| +41% | +$7.84M | 0.01% | 1038 |
|
|
2024
Q1 | $21.1M | Buy |
287,700
+137,100
| +91% | +$10.5M | ﹤0.01% | 1145 |
|
|
2023
Q4 | $12.2M | Sell |
150,600
-1,800
| -1% | -$140K | ﹤0.01% | 1740 |
|
|
2023
Q3 | $11.4M | Buy |
152,400
+58,700
| +63% | +$4.51M | ﹤0.01% | 1639 |
|
|
2023
Q2 | $7.22M | Sell |
93,700
-8,900
| -9% | -$710K | ﹤0.01% | 2271 |
|
|
2023
Q1 | $8.51M | Sell |
102,600
-418,000
| -80% | -$34.6M | ﹤0.01% | 1803 |
|
|
2022
Q4 | $44.7M | Buy |
520,600
+101,500
| +24% | +$8.04M | 0.02% | 580 |
|
|
2022
Q3 | $25.9M | Sell |
419,100
-124,900
| -23% | -$7.88M | 0.01% | 880 |
|
|
2022
Q2 | $33.6M | Sell |
544,000
-785,500
| -59% | -$48.6M | 0.01% | 761 |
|
|
2022
Q1 | $79M | Buy |
1,329,500
+33,700
| +3% | +$2.15M | 0.03% | 481 |
|
|
2021
Q4 | $94.1M | Buy |
1,295,800
+470,200
| +57% | +$32.4M | 0.03% | 392 |
|
|
2021
Q3 | $57.7M | Buy |
825,600
+347,700
| +73% | +$24.4M | 0.02% | 545 |
|
|
2021
Q2 | $32.9M | Buy |
477,900
+25,000
| +6% | +$1.67M | 0.01% | 765 |
|
|
2021
Q1 | $29.3M | Sell |
452,900
-211,300
| -32% | -$13.6M | 0.01% | 719 |
|
|
2020
Q4 | $38.7M | Sell |
664,200
-312,600
| -32% | -$18.9M | 0.02% | 540 |
|
|
2020
Q3 | $61.7M | Buy |
976,800
+212,700
| +28% | +$14.7M | 0.04% | 328 |
|
|
2020
Q2 | $58.8M | Sell |
764,100
-46,800
| -6% | -$3.59M | 0.04% | 309 |
|
|
2020
Q1 | $60.6M | Buy |
810,900
+579,800
| +251% | +$40.1M | 0.06% | 215 |
|
|
2019
Q4 | $15M | Buy |
231,100
+44,500
| +24% | +$2.9M | 0.02% | 483 |
|
|
2019
Q3 | $11.8M | Buy |
186,600
+32,700
| +21% | +$2.14M | 0.02% | 523 |
|
|
2019
Q2 | $10.4M | Buy |
153,900
+107,700
| +233% | +$7.09M | 0.02% | 615 |
|
|
2019
Q1 | $3M | Sell |
46,200
-26,600
| -37% | -$1.77M | ﹤0.01% | 1585 |
|
|
2018
Q4 | $4.55M | Buy |
72,800
+47,700
| +190% | +$3.33M | 0.01% | 1006 |
|
|
2018
Q3 | $1.94M | Sell |
25,100
-67,100
| -73% | -$5.07M | ﹤0.01% | 1943 |
|
|
2018
Q2 | $6.53M | Sell |
92,200
-24,000
| -21% | -$1.69M | 0.02% | 851 |
|
|
2018
Q1 | $8.76M | Sell |
116,200
-120,800
| -51% | -$9.6M | 0.02% | 600 |
|
|
2017
Q4 | $17M | Buy |
237,000
+21,000
| +10% | +$1.59M | 0.05% | 333 |
|
|
2017
Q3 | $17.5M | Sell |
216,000
-2,000
| -0.9% | -$153K | 0.06% | 302 |
|
|
2017
Q2 | $15.4M | Buy |
218,000
+69,100
| +46% | +$4.6M | 0.05% | 304 |
|
|
2017
Q1 | $10.1M | Sell |
148,900
-30,000
| -17% | -$2.11M | 0.05% | 380 |
|
|
2016
Q4 | $12.8M | Buy |
178,900
+21,100
| +13% | +$1.57M | 0.06% | 278 |
|
|
2016
Q3 | $12.5M | Sell |
157,800
-67,100
| -30% | -$5.45M | 0.06% | 260 |
|
|
2016
Q2 | $18.8M | Buy |
224,900
+62,400
| +38% | +$5.54M | 0.09% | 199 |
|
|
2016
Q1 | $14.9M | Buy |
162,500
+50,200
| +45% | +$4.53M | 0.08% | 209 |
|
|
2015
Q4 | $11.4M | Sell |
112,300
-33,400
| -23% | -$3.48M | 0.07% | 243 |
|
|
2015
Q3 | $14.3M | Buy |
145,700
+95,700
| +191% | +$10.6M | 0.09% | 188 |
|
|
2015
Q2 | $5.85M | Sell |
50,000
-50,600
| -50% | -$5.53M | 0.04% | 399 |
|
|
2015
Q1 | $9.87M | Buy |
100,600
+11,400
| +13% | +$1.16M | 0.08% | 221 |
|
|
2014
Q4 | $8.41M | Buy |
89,200
+82,400
| +1,212% | +$8.52M | 0.06% | 225 |
|
|
2014
Q3 | $724K | Buy |
+6,800
| New | +$666K | 0.01% | 1147 |
|
Other funds holding GILD
VCM
VPM
Jane Street's GILD Position: Q1 2026 in Review
Jane Street increased its Gilead Sciences (GILD) stake by 1,000% in Q1 2026, buying an estimated $84.9M and bringing the position to 666,637 shares worth $92.9M. The position accounts for 0.01% of the portfolio, ranked #677.
Jane Street first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $98.2M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Jane Street held 666,637 shares of Gilead Sciences worth $92.9M as of Q1 2026.
- Jane Street bought 606,009 Gilead Sciences shares in Q1 2026, an estimated $84.9M.
- Gilead Sciences made up 0.01% of Jane Street's portfolio in Q1 2026, its #677 holding.
- Jane Street first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Jane Street's Gilead Sciences position peaked at $98.2M in Q3 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.